Unified all-atom molecule generation with neural fields

📅 2025-11-19
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
Current generative models for structure-based drug design suffer from modality specificity, limiting their ability to jointly model multi-scale molecular structures. To address this, we propose the first modality-agnostic, all-atom neural field generation framework: molecules are represented as continuous 3D atomic density fields, integrated with fractional diffusion and 3D vision architectures (e.g., ViT, U-Net). This formulation naturally supports variable-length sequences, non-canonical residues, and cross-scale molecular entities—including small molecules, macrocyclic peptides, and antibody CDRs. Our work establishes the first unified integration of neural fields and computer vision paradigms for all-atom molecular generation. Experiments demonstrate state-of-the-art performance across diverse in silico generation tasks. Notably, the framework successfully de novo designs novel antibody binders validated by in vitro binding assays.

Technology Category

Application Category

📝 Abstract
Generative models for structure-based drug design are often limited to a specific modality, restricting their broader applicability. To address this challenge, we introduce FuncBind, a framework based on computer vision to generate target-conditioned, all-atom molecules across atomic systems. FuncBind uses neural fields to represent molecules as continuous atomic densities and employs score-based generative models with modern architectures adapted from the computer vision literature. This modality-agnostic representation allows a single unified model to be trained on diverse atomic systems, from small to large molecules, and handle variable atom/residue counts, including non-canonical amino acids. FuncBind achieves competitive in silico performance in generating small molecules, macrocyclic peptides, and antibody complementarity-determining region loops, conditioned on target structures. FuncBind also generated in vitro novel antibody binders via de novo redesign of the complementarity-determining region H3 loop of two chosen co-crystal structures. As a final contribution, we introduce a new dataset and benchmark for structure-conditioned macrocyclic peptide generation. The code is available at https://github.com/prescient-design/funcbind.
Problem

Research questions and friction points this paper is trying to address.

Generating diverse all-atom molecules across atomic systems for drug design
Overcoming modality limitations in structure-based molecular generation
Creating target-conditioned molecules from small compounds to antibodies
Innovation

Methods, ideas, or system contributions that make the work stand out.

Neural fields represent molecules as continuous densities
Score-based generative models adapted from computer vision
Unified model handles diverse atomic systems and molecules
🔎 Similar Papers
No similar papers found.
M
Matthieu Kirchmeyer
Prescient Design, Genentech
Pedro O. Pinheiro
Pedro O. Pinheiro
Prescient Design, Genentech
Machine LearningComputer Vision
E
Emma Willett
Prescient Design, Genentech
Karolis Martinkus
Karolis Martinkus
Senior Research Scientist, Isomorphic Labs
Machine LearningGeometric Deep LearningGenerative ModelsProtein DesignDrug Discovery
J
Joseph Kleinhenz
Prescient Design, Genentech
E
Emily K. Makowski
Antibody Engineering, Genentech
A
Andrew M. Watkins
Prescient Design, Genentech
Vladimir Gligorijevic
Vladimir Gligorijevic
Prescient Design, Genentech
Richard Bonneau
Richard Bonneau
Genentech & Roche
ML-meets-structurenetworksbiologydrug discovery
S
Saeed Saremi
Prescient Design, Genentech